Clinical Trials Browser

Terminated × INDUSTRY × ARQ 197 × Clear all

NCT01055067 2021-04-06

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Phase 2 Terminated

27 enrolled 6 charts

Seminoma

NCT01244191 2021-04-06

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Phase 3 Terminated

1,048 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT01377376 2016-12-07

ATTENTION

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung